Effects of rivastigmine in patients with traumatic brain injury with cognitive deficits: Results of a 12-week double-blind study

被引：0
|
作者：
Mirski, D
Koumaras, B
Chen, M
Potkin, S
Silver, J
机构：
来源：
ANNALS OF NEUROLOGY | 2005年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 50 条
  • [41] Adding memantine to therapy with rivastigmine in patients with mild to moderate Alzheimer's disease: Results of a 12-week pilot study
    Riepe, MW
    Adler, G
    Ibach, B
    Tracik, F
    NEUROLOGY, 2005, 64 (06) : A363 - A364
  • [42] Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double-blind placebo-controlled study
    Schneider, WN
    Drew-Cates, J
    Wong, TM
    Dombovy, ML
    BRAIN INJURY, 1999, 13 (11) : 863 - 872
  • [43] High doses of cholecalciferol alleviate the progression of hyperparathyroidism in patients with CKD Stages 3-4: results of a 12-week double-blind, randomized, controlled study
    Westerberg, Per-Anton
    Sterner, Gunnar
    Ljunggren, Osten
    Isaksson, Elin
    Elvarson, Fjolnir
    Dezfoolian, Hamid
    Linde, Torbjorn
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (03) : 466 - 471
  • [44] Effects of Simvastatin on Plasma Amyloid-β Transport in Patients with Hyperlipidemia: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial
    Wei, Shan
    Dang, Liangjun
    Gao, Fan
    Wang, Jingyi
    Wang, Jin
    Qu, Qiumin
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 90 (01) : 349 - 362
  • [45] Extended-release physostigmine in Alzheimer disease -: A multicenter, double-blind, 12-week study with dose enrichment
    van Dyck, CH
    Newhouse, P
    Falk, WE
    Mattes, JA
    ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (02) : 157 - 164
  • [46] Pramipexole for Chinese people with primary restless legs syndrome: a 12-week multicenter, randomized, double-blind study
    Zhang, Jingyu
    Liu, Bin
    Zheng, Yonghui
    Chu, Tingting
    Yang, Zichao
    SLEEP MEDICINE, 2015, 16 (01) : 181 - 185
  • [47] Effects of Probucol on plasma amyloid-β transport in patients with hyperlipidemia: a 12-week randomized, double-blind, placebo-controlled trial
    Dang, Liangjun
    Wei, Shan
    Zhao, Yi
    Zhou, Rong
    Shang, Suhang
    Gao, Fan
    Wang, Jingyi
    Wang, Jin
    Qu, Qiumin
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [48] A 12-week randomized double-blind clinical trial of eicosapentaenoic acid intervention in episodic migraine
    You, Zhi-bo
    Cao, Piao
    BRAIN BEHAVIOR AND IMMUNITY, 2024, 121 : 121 - 121
  • [49] A 12-week randomized double-blind clinical trial of eicosapentaenoic acid intervention in episodic migraine
    Wang, Hsueh-Fang
    Liu, Wen -Chun
    Zailani, Halliru
    Chen, Ting-Bin
    Yang, Cheng-Chia
    Chang, Ching -Mao
    Tsai, I-Ju
    Yang, Chun-Pai
    Su, Kuan-Pin
    BRAIN BEHAVIOR AND IMMUNITY, 2024, 118 : 459 - 467
  • [50] A randomized, double-blind, parallel-group, phase III study of shortening the dosing interval of subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis and an inadequate response to subcutaneous tocilizumab every other week: Results of the 12-week double-blind period
    Ogata, Atsushi
    Tanaka, Yoshiya
    Ishii, Tomonori
    Kaneko, Motohide
    Miwa, Hiroko
    Ohsawa, Shino
    MODERN RHEUMATOLOGY, 2018, 28 (01) : 76 - 84
12345